New research findings on onset of uterine fibroids provide potential for novel treatments
Key points
- Uterine leiomyomata, or fibroids, are benign tumours that nevertheless affect the health of millions of women.
- Scientists at the Academy of Finland's Centre of Excellence in Cancer Genetics Research have identified the molecular mechanisms underlying the onset of common leiomyomata.
- "These new findings are essential for the further development of pharmacological treatments for this type of tumour," says Academy Professor Lauri Aaltonen, who heads the Centre the Excellence based at the University of Helsinki.
- Aaltonen's team has demonstrated how the genome of benign uterine leiomyomata differs from normal uterine tissue.
Uterine leiomyomata, or fibroids, are benign tumours that nevertheless affect the health of millions of women. They may cause, for instance, pain, bleeding and infertility. Fibroids are also the most common reason for a hysterectomy; for example, some 8,000 hysterectomies are made in Finland each year.
Scientists at the Academy of Finland's Centre of Excellence in Cancer Genetics Research have identified the molecular mechanisms underlying the onset of common leiomyomata. The results of their research were published in the top medical journal New England Journal of Medicine in early June.
"These new findings are essential for the further development of pharmacological treatments for this type of tumour," says Academy Professor Lauri Aaltonen, who heads the Centre the Excellence based at the University of Helsinki.
Aaltonen's team has demonstrated how the genome of benign uterine leiomyomata differs from normal uterine tissue. Very little was known about the aetiology of leiomyomata before the team's research. The team has previously identified a gene defect that explains more than half of these tumours. The present whole-genome sequencing proved that most of the rest of the tumours develop as a result of chromosome fragmentation and rearrangements.
"Complex chromosomal rearrangements are a major cause of cellular changes that contribute to the onset of benign uterine leiomyomata," Aaltonen states.
Similar changes resulting from chromosomal rearrangements are normally identified in malignant tumours. The results of Aaltonen's team suggest that the same mechanisms may also underlie the onset of non-cancerous tumours.
"Our research also indicates what mechanisms may prevent benign tumours from becoming malignant," Aaltonen adds.
###
More information:
Academy Professor Lauri Aaltonen
University of Helsinki
lauri.aaltonen(at)helsinki.fi
tel. +358 44 9498352
Communications Manager Riitta Tirronen
Academy of Finland
tel. +358 29 533 5118
riitta.tirronen(at)aka.fi
PR & Press Officer Päivi Lehtinen
University of Helsinki
tel. +358 50 406 2043
paivi.m.lehtinen(at)helsinki.fi
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsFindings May Help Explain Some Major Clinical Symptoms of Preeclampsia
Virginia Commonwealth University School of Medicine researchers have found that a significant increase of an enzyme in the blood vessels of pregnant women with preeclampsia may explain some of the symptoms associated…
6 January 2011
NewsVCU findings may help explain some major clinical symptoms of preeclampsia
Virginia Commonwealth University School of Medicine researchers have found that a significant increase of an enzyme in the blood vessels of pregnant women with preeclampsia may explain some of the symptoms associated…
5 January 2011
NewsU of M research finds ovulating women unconsciously buy sexier clothing to outdo attractive women
Ovulating women unconsciously buy sexier clothes, says new research from the University of Minnesota's Carlson School of Management. The study finds that ovulating women unconsciously dress to impress – doing so not to…
